Adam Laponis, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 8,034 shares at $31.15 ($259K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Scheduled sale ($259k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.15 | 3,000 | $93K | 36.1% |
| 2 | $32.92 | 2,517 | $83K | 32.0% |
| 3 | $32.92 | 2,517 | $83K | 32.0% |
| Total | $32.26 avg | 8,034 | $259K | 100% |
| Filing → |
| TWST | SELL | 2026-07-13 | $226K | — | Filing → |
| TWST | SELL | 2026-06-02 | $280K | — | Filing → |
| TWST | SELL | 2026-05-26 | $108K | — | Filing → |